Recurrent Rectal Adenocarcinoma
3 clinical trials · Condition
◉ Watch Recurrent Rectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924) | Roswell Park Cancer Institute | 2019-12-27 |
| Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer (NCT02874885) | M.D. Anderson Cancer Center | 2013-09-05 |
Track Recurrent Rectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.